⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OABI News
OmniAb, Inc. Common Stock
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
globenewswire.com
VRXA
OABI
Form 8-K
sec.gov
OABI
OABIW
Form 8-K
sec.gov
OABIW
OABI
Form 8-K
sec.gov
OABI
OABIW
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights
businesswire.com
OABI
OmniAb to Participate in Three Upcoming Investor Conferences
businesswire.com
OABI
OmniAb to Report First Quarter 2026 Financial Results on May 7
businesswire.com
OABI
Form 8-K
sec.gov
OABI
OABIW
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
businesswire.com
OABI
OmniAb to Participate at the Leerink Partners Global Healthcare Conference
businesswire.com
OABI